(Q45924945)

17 December 2017

title

A valuation of patients' willingness-to-pay for insulin delivery in diabetes. (English)

1 reference

17 December 2017

1 reference

Camila Guimarães

1

1 reference

17 December 2017

Carlo A Marra

2

1 reference

17 December 2017

Lindsey Colley

3

1 reference

17 December 2017

Sabrina Gill

4

1 reference

17 December 2017

Scot H Simpson

5

1 reference

17 December 2017

Graydon S Meneilly

6

1 reference

17 December 2017

Regina H C Queiroz

7

1 reference

17 December 2017

Larry D Lynd

8

1 reference

17 December 2017

publication date

1 July 2009

1 reference

17 December 2017

International Journal of Technology Assessment in Health Care

published in

1 reference

17 December 2017

volume

25

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

359-366

1 reference

17 December 2017

Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

A comparison of four indirect methods of assessing utility values in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

Reconcilable differences: a cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting beta-agonist use in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

Willingness to pay for complete symptom relief of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

The discrete-choice willingness-to-pay question format in health economics: should we adopt environmental guidelines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

Willingness to pay for inhaled insulin: a contingent valuation approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

The Economic Cost of Diabetes in Canada, 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

Eliciting public preferences for healthcare: a systematic review of techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

7 January 2021

When oral agents fail: practical barriers to starting insulin

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

7 January 2021

Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

7 January 2021

Measuring willingness-to-pay for risk reduction: an application of conjoint analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990055

7 January 2021

10.1017/S0266462309990055

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017